Rankings
▼
Calendar
LIVN Q1 2021 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena
LIVN
LivaNova PLC
$3B
Q1 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$248M
+2.1% YoY
Gross Profit
$163M
66.0% margin
Operating Income
-$6M
-2.3% margin
Net Income
-$31M
-12.4% margin
EPS (Diluted)
$-0.61
QoQ Revenue Growth
-8.1%
Cash Flow
Operating Cash Flow
$19M
Free Cash Flow
$11M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$2.4B
Total Liabilities
$1.3B
Stockholders' Equity
$1.1B
Cash & Equivalents
$253M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$248M
$242M
+2.1%
Gross Profit
$163M
$171M
-4.2%
Operating Income
-$6M
$23M
-124.7%
Net Income
-$31M
$38M
-181.8%
Revenue Segments
Cardiovascular Segment
$143M
58%
Neuromodulation Segment
$104M
42%
Geographic Segments
UNITED STATES
$133M
54%
Locations Excluding The United States And Europe
$63M
26%
Europe
$51M
21%
← FY 2021
All Quarters
Q2 2021 →